Speaker: Dr Brian Walker MLC, Legalise Cannabis Party (WA)
About: The rediscovery of the endocannabinoid system (ECS) in the 1990s marked a fundamental shift in human physiology, revealing a ubiquitous homeostatic network interwoven through the immune, neurological, and endocrine systems. Yet, despite its centrality, this system remains absent from most medical curricula. This epistemic blind spot has profound implications for clinicians treating complex, multi-systemic disorders that defy conventional diagnostic reductionism—one among them the intersecting triad of Dysautonomia, Ehlers–Danlos Syndrome (EDS), and Autism Spectrum Disorder (ASD). These three conditions, though traditionally siloed, share convergent pathophysiological pathways involving connective tissue dysregulation, autonomic instability, and neurodevelopmental divergence, all of which are intimately modulated by the ECS.
This presentation explores the hypothesis that ECS dysfunction forms a mechanistic bridge between these syndromes, influencing both neurocognitive regulation and connective tissue integrity. Evidence suggests that altered endocannabinoid tone—particularly low anandamide and impaired CB1/CB2 receptor signalling—may contribute to autonomic dysregulation, sensory hypersensitivity, and neuroinflammatory processes observed across the triad. Furthermore, emerging genetic correlations implicate shared variants affecting collagen synthesis and dopamine-serotonin pathways, reinforcing the need for integrative, cross-disciplinary diagnostic thinking.
Clinical recognition of this triad is often delayed, as symptoms of fatigue, anxiety, pain, or inattention are fragmented across specialties. Hypermobile patients may be mislabelled as somatising; neurodivergent individuals are too often pathologised or medicated without addressing underlying autonomic or inflammatory dysfunction. In this context, medical cannabis therapy provides both a diagnostic and therapeutic lens. Cannabinoid modulation—particularly CBD-dominant formulations—targets the very axes of dysregulation common to these syndromes: neuroinflammation, hypothalamic-pituitary-adrenal overactivation, and autonomic imbalance. Observational data from Israeli and Australian cohorts demonstrate symptomatic improvement in 60–80% of neurodivergent patients using high-CBD regimens, with notable gains in anxiety reduction, sleep quality, and behavioural regulation.
However, prescribing cannabinoids to neurodivergent or dysautonomic patients demands clinical sophistication well beyond standard general practice. The practitioner must discern subtle ECS tone variations, appreciate paradoxical responses to stimulants or antipsychotics, and tailor cannabinoid ratios to the patient’s neurobiological phenotype. A simplistic “symptom-management” paradigm is inadequate. Instead, the clinician must function as a systems diagnostician, integrating neurophysiology, psychopharmacology, and connective-tissue medicine within a unified biopsychosocial framework.
This, then, is the “heresy” of medical cannabis: it challenges the intellectual complacency of mechanistic medicine by demanding that its practitioners become more—not less—scientifically rigorous, diagnostically nuanced, and therapeutically creative. Mastery in cannabinoid medicine requires a re-education in human homeostasis itself. In embracing the ECS, clinicians move beyond treating isolated symptoms to restoring physiological harmony.
Ultimately, the responsible cannabis clinician is not a drug prescriber but a homeostatic restorer—an expert diagnostician who must, by necessity, surpass the traditional boundaries of general practice. Only through this deeper understanding can medicine reclaim its most ancient and future-facing role: to heal by restoring balance.
Bio: Brian is an Australian politician and medical practitioner with over 40 years of experience, spanning many continents and cultures. His passion is making this world a better place for our children and grandchildren. Born in Malaysia to Scottish parents, he received his education at Scotch College in Perth before earning his medical degree at the University of Dundee, Scotland. Brian’s medical career has seen him practice across the globe—from the cutting-edge hospitals of Germany, the Soviet Union, the UK, and Hong Kong, to his eventual return home to Western Australia in 2008, where he established a specialist GP practice in the Perth Hills. Since being elected in 2021 as leader of the Legalise Cannabis WA Party, Dr Walker has been a strong voice for reform, challenging outdated laws and advocating for modern, science-backed policies. With his deep understanding of medicine and health, he brings a fresh, holistic perspective to the political arena, focusing on improving the medical, mental, social, and economic wellbeing of all Australians.
www.brianwalkermlc.com.au
https://www.youtube.com/@brianwalkermlc
https://www.linkedin.com/in/brianwalkermlc/
https://www.facebook.com/BrianWalkerMLC
